Drug recall · April 5, 2017
Montelukast sodium tablets recall
Why: Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Montelukast sodium tablets, 10 mg, 30-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: HETERO Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-726-30
- Lots / codes
Lot # MON16001B, Exp 01/18
- Quantity
- 65,664 bottles
- Company
- Hetero USA Inc, Piscataway, NJ
- Distribution
- US Nationwide
- Initiated
- January 7, 2017 · Voluntary: Firm initiated
- Classified
- March 29, 2017
- Reported
- April 5, 2017
- Ended
- August 8, 2017
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Montelukast
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.